Induction of Apoptosis by Cationic Amphiphilic Drugs Amiodarone and Imipramine

2005 ◽  
Vol 28 (1) ◽  
pp. 117-133 ◽  
Author(s):  
Joseph R. Piccotti ◽  
Mark S. LaGattuta ◽  
Stephanie A. Knight ◽  
Andrea J. Gonzales ◽  
Michael R. Bleavins
2020 ◽  
Author(s):  
Anne-Marie Ellegaard ◽  
Peter Bach ◽  
Marja Jäättelä

2018 ◽  
Vol 47 (1) ◽  
pp. 26-34 ◽  
Author(s):  
Yoshinori Yamagiwa ◽  
Yoshihiro Takei ◽  
Haruko Koizumi ◽  
Shingo Nemoto ◽  
Masaaki Kurata ◽  
...  

Cationic amphiphilic drugs (CADs) can induce phospholipidosis (PLD) in organs/tissues. Several ophthalmic pharmaceuticals containing CADs are marketed and used in children. To investigate the effect of PLD on the developing cornea, chloroquine and amiodarone, which are representative CADs, were applied topically to the eyes of juvenile rabbits, and the effects in juvenile rabbits were compared with those in young adult rabbits. Diffuse corneal cloudiness was observed in chloroquine- and amiodarone-treated eyes. Histopathologically, vacuolation was observed in the corneal epithelium and keratocytes. On ultrastructural examination, these vacuoles contained multilamellar inclusion bodies, which are a characteristic of PLD. The size of the vacuoles in the corneal epithelium was reduced in juveniles compared with young adults. Cytoplasmic lamellar bodies and exocytosis in the corneal endothelium were observed in young adult rabbits but not in juvenile rabbits. This study revealed that topical application of chloroquine or amiodarone induces corneal PLD in juvenile and young adult rabbits. Corneal endothelial changes occurred only in young adult rabbits, but ophthalmological changes were similar between juveniles and young adults. The results of the study suggest that the effects of corneal PLD were similar among age groups based on risk assessment.


2020 ◽  
Vol 10 ◽  
Author(s):  
Michelle Hu ◽  
Kermit L. Carraway

A major confounding issue in the successful treatment of cancer is the existence of tumor cell populations that resist therapeutic agents and regimens. While tremendous effort has gone into understanding the biochemical mechanisms underlying resistance to each traditional and targeted therapeutic, a broader approach to the problem may emerge from the recognition that existing anti-cancer agents elicit their cytotoxic effects almost exclusively through apoptosis. Considering the myriad mechanisms cancer cells employ to subvert apoptotic death, an attractive alternative approach would leverage programmed necrotic mechanisms to side-step therapeutic resistance to apoptosis-inducing agents. Lysosomal cell death (LCD) is a programmed necrotic cell death mechanism that is engaged upon the compromise of the limiting membrane of the lysosome, a process called lysosomal membrane permeabilization (LMP). The release of lysosomal components into the cytosol upon LMP triggers biochemical cascades that lead to plasma membrane rupture and necrotic cell death. Interestingly, the process of cellular transformation appears to render the limiting lysosomal membranes of tumor cells more fragile than non-transformed cells, offering a potential therapeutic window for drug development. Here we outline the concepts of LMP and LCD, and discuss strategies for the development of agents to engage these processes. Importantly, the potential exists for existing cationic amphiphilic drugs such as antidepressants, antibiotics, antiarrhythmics, and diuretics to be repurposed to engage LCD within therapy-resistant tumor cell populations.


Metabolomics ◽  
2020 ◽  
Vol 16 (9) ◽  
Author(s):  
Inger Ødum Nielsen ◽  
Line Groth-Pedersen ◽  
Jano Dicroce-Giacobini ◽  
Anna Sofie Holm Jonassen ◽  
Monika Mortensen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document